Concepedia

Argyrides Argyrou

AA

31

Publications

1.5K

Citations

24

H-Index

1999

Active since

Affiliations

Albert Einstein College of Medicine(Current)

GlaxoSmithKline (United Kingdom)

GlaxoSmithKline (Spain)

AstraZeneca (United States)

AstraZeneca (United Kingdom)

Argyrides Argyrou is an author at Albert Einstein College of Medicine specializing in medicine, biochemistry, and molecular biology.

ORCID

Top concepts

Publications per year

1999–2024

31

Publications

31

EED-Targeted PROTACs Degrade EED, EZH2, and SUZ12 in the PRC2 Complex

Jessie Hao-Ru Hsu, Timothy Rasmusson, James Robinson et al. · Cell chemical biology · 2019 · 192 citations · Full text

, ,

Mycobacterium tuberculosis dihydrofolate reductase is a target for isoniazid

Argyrides Argyrou, M.W. Vetting, Bola Aladegbami et al. · Nature Structural & Molecular Biology · 2006 · 126 citations

, , +4

Enabling Lead Discovery for Histone Lysine Demethylases by High-Throughput RapidFire Mass Spectrometry

Sue Hutchinson, Melanie Leveridge, Michelle L. Heathcote et al. · SLAS DISCOVERY · 2011 · 99 citations · Full text

<i>N</i> -methylation of a bactericidal compound as a resistance mechanism in <i>Mycobacterium tuberculosis</i>

Thulasi Warrier, Kanishk Kapilashrami, Argyrides Argyrou et al. · Proceedings of the National Academy of Sciences · 2016 · 97 citations · Full text

Identification of KasA as the cellular target of an anti-tubercular scaffold

Katherine A. Abrahams, Chun-wa Chung, Sonja Ghidelli‐Disse et al. · Nature Communications · 2016 · 96 citations · Full text

Rows per page

1–5 of 31